Your institution may have access to this item. Find your institution then sign in to continue.
Title
Ranbaxy in pole position.
Abstract
The article reports on the growth of Ranbaxy Australia Pty. Ltd. in Australia. It relates the plan of the company to have a generic partner in 2012 and to launch a generic version of all the major molecules due to expire this year. Moreover, the company considers that the new round of patent expiries will require a new launch approach designed to support long tem financial strategies of pharmaceutical services.